Bank Of America Corp Hepion Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.27 - $11.9 $47 - $2,082	175 Added 3500.0%	180 $0
Q1 2022 May 16, 2022	SELL	$0.93 - $1.29 $28,963 - $40,175	-31,144 Reduced 99.98%	5 $0
Q4 2021 Feb 08, 2022	SELL	$1.14 - $1.58 $974 - $1,350	-855 Reduced 2.67%	31,149 $35,000
Q3 2021 Nov 15, 2021	BUY	$1.39 - $2.1 $43,383 - $65,543	31,211 Added 3935.81%	32,004 $49,000
Q2 2021 Sep 13, 2021	BUY	$1.56 - $2.26 $1,237 - $1,792	793 New	793 $2,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $49.5M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.